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Abstract
Ultradian glucocorticoid rhythms are highly conserved across mammalian species, how-
ever, their functional significance is not yet fully understood. Here we demonstrate that pul-
satile corticosterone replacement in adrenalectomised rats induces a dynamic pattern of
glucocorticoid receptor (GR) binding at ~3,000 genomic sites in liver at the pulse peak, sub-
sequently not found during the pulse nadir. In contrast, constant corticosterone replacement
induced prolonged binding at the majority of these sites. Additionally, each pattern further
induced markedly different transcriptional responses. During pulsatile treatment, intragenic
occupancy by active RNA polymerase II exhibited pulsatile dynamics with transient changes
in enrichment, either decreased or increased depending on the gene, which mostly returned
to baseline during the inter-pulse interval. In contrast, constant corticosterone exposure
induced prolonged effects on RNA polymerase II occupancy at the majority of gene targets,
thus acting as a sustained regulatory signal for both transactivation and repression of gluco-
corticoid target genes. The nett effect of these differences were consequently seen in the
liver transcriptome as RNA-seq analysis indicated that despite the same overall amount of
corticosterone infused, twice the number of transcripts were regulated by constant cortico-
sterone infusion, when compared to pulsatile. Target genes that were found to be differen-
tially regulated in a pattern-dependent manner were enriched in functional pathways
including carbohydrate, cholesterol, glucose and fat metabolism as well as inflammation,
suggesting a functional role for dysregulated glucocorticoid rhythms in the development of
metabolic dysfunction.
Author summary
Adrenal glucocorticoid hormones are released in a characteristic ultradian rhythm that
becomes dysregulated during chronic stress, disease, or synthetic corticosteroid treatment.
PLOS GENETICS
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Metabolic dysfunction is a comorbidity associated with all these conditions, but the role
that altered glucocorticoid dynamics play is unknown. As the liver is a major site of gluco-
corticoid action on metabolic homeostasis regulated by the glucocorticoid receptor, we
have assessed how different patterns of hormone replacement in adrenalectomised rats
differentially regulate gene pathways involved in type II diabetes, cirrhosis, and fatty liver
development, via altering the pattern of glucocorticoid receptor binding to regulatory
sites. We believe our findings have important implications for therapies that can repro-
duce the endogenous glucocorticoid rhythm and thus minimize adverse metabolic side-
effects in patients.
Introduction
In mammals, glucocorticoid (GC) release from the adrenal glands is under the regulation of
the hypothalamic pituitary adrenal (HPA) axis [1]. Entrained to the photoperiod, and regu-
lated by the hypothalamic suprachiasmatic nucleus [2], maximal GC release occurs prior to
awakening and gradually decreases throughout the active period before returning to basal lev-
els at the onset of the inactive period, in a classical 24 hr circadian profile. The vast majority of
GC rhythm research has focussed on this circadian profile using 6–12 hr data collection inter-
vals, however, automated blood microsampling at 10 min intervals has led to the detection of a
pronounced underlying rhythm of rising and falling phases with a periodicity of 56–60 min
for corticosterone (CORT) in rat [3] and 95–180 min for cortisol in man [4,5]. The origin of
the ultradian rhythm within the circadian rhythm has been shown both mathematically and
experimentally to emerge as a consequence of a sub-hypothalamic pulse generator, where
intrinsic delays in pituitary adrenal communication exist in both the positive feed-forward and
negative feedback arms of the loop [6]. As GC oscillations are highly conserved across mam-
malian species [7], and bioavailable ‘free’ GC pulses can be detected by microdialysis in the
extracellular fluid of a variety of tissues [8,9] in experimental rodents and in man [10,11], we
propose that this dynamic hormone signal may be crucial for optimal tissue specific responses
to GC secretion throughout the body.
Adrenal GCs regulate multiple physiological processes via regulation of glucocorticoid
receptors present in almost all tissues of the body, thus affecting immunological and stress
responses, cognitive processes, cardiovascular regulation, and a range of metabolic processes
including glucose, lipid, fatty acid and triglyceride homeostasis. GCs promote gluconeogenesis
in the liver, whereas they decrease glucose uptake and utilisation in skeletal muscle and white
adipose tissue by antagonising insulin response. Excess GC exposure causes hyperglycaemia
and insulin resistance. GCs also regulate glycogen metabolism [12]. Associations between ele-
vated circulating GCs and metabolic disease are well known. For example, Cushing’s disease,
which is characterised by hypercortisolism, is associated with a myriad of metabolic co-mor-
bidities including increased visceral fat deposits, obesity and dyslipidaemia; furthermore, type
II diabetes occurs in at least a third of Cushing’s patients [13]. Synthetic GCs (sGCs), which
are often more potent and have longer plasma half-lives than their endogenous counterparts
[14,15], can cause a similar pattern of adverse metabolic side effect. Patients prescribed GC
treatment have a higher incidence of metabolic disease, including diabetes, compared to
patients on other medications [16–19]. There has been considerable investigation of the mech-
anisms underlying these side effects over the past decade and whilst dose is certainly a well-rec-
ognised risk factor, efforts to reduce doses towards physiological levels is often insufficient to
prevent the development of metabolic disturbance over a prolonged period [20]. GCs regulate
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gene transcription in target cells via a ligand activated transcription factor, the glucocorticoid
receptor (GR). Activated GR is directed to specific sites across the genome, either by direct
binding to short consensus DNA sequences termed glucocorticoid response elements (GREs)
or via tethering by other transcription factors. GR then recruits co-factors such as the histone
acetyl transferase enzymes CBP/P300 and the ATP-dependent Swi/Snf chromatin remodelling
complex to reposition nucleosomes and allow increased accessibility for RNA polymerase II
(RNAPol2) and related transcriptional machinery to the transcriptional start site (TSS) of tar-
get genes [21,22]. Conversely, decreased access of RNAPol2 to the TSS of target genes results
in transcriptional down-regulation. In this way, GCs can induce either up-regulation or down-
regulation of a vast number of target genes in a highly gene-specific, cell-specific and context-
specific manner.
Studies using high-dose pulsed CORT treatment in adrenalectomised rats [23] have dem-
onstrated that GR binds transiently to GREs regulating the transcription of the ‘hypersensitive’
Period 1 gene [24] in multiple cells and tissues throughout the body and brain [14,25,26]. In
rat liver, GR binding at Per1 regulatory GREs reached maximal levels at the peak of an hourly
induced CORT pulse before fully dissociating within the 40 min period of CORT clearance
from the circulation [14]. Despite the supraphysiological CORT dose, synchronised recruit-
ment and loss from the DNA template was repeated over the series of pulses and was found to
induce similarly synchronised, if slightly delayed, enrichment of RNAPol2 at the Per1 TSS and
hnRNA production within liver [14] as well as brain tissue [25] which was consistent with
observations in a variety of cell lines [14,25–28]. More recently, assessment of genome-wide
GR binding and RNAPol2 enrichment at the TSS in a murine mammary cell line (3617)
revealed recruitment and loss synchronised to ultradian corticosterone replacement patterns
at a vast number of targets, and these dynamics were ablated by constant CORT treatment
[28]. What has remained unknown, until now, is how these genome-wide dynamics are
affected during ultradian versus constant CORT exposure in a live animal. Furthermore, as it
is now well accepted that cell-specific chromatin architecture will pre-determine a different
GC-target transcriptome in liver compared to 3617 cells, it is extremely important to assess
how transcriptional regulation of physiologically relevant GC-target genes associated with
metabolic function are affected by disrupted GC exposure and how this may relate to meta-
bolic function / dysfunction in the whole animal.
Here, we demonstrate that genome-wide GR binding dynamics in liver are tightly regulated
by a pulsatile CORT infusion (PULS). In contrast, a dose-matched constant CORT infusion
(CONS) results in widespread disruption of ultradian GR dynamics, with subsequent impact
upon RNAPol2 recruitment to liver-specific GC regulated genes and significant pattern depen-
dent effects on the GC regulated liver transcriptome. We have identified key metabolic targets
that are sensitive to altered CORT exposure, thus highlighting metabolic pathways that are
acutely susceptible to GC dysregulation, with implications for the development of the clinically
important metabolic syndrome in patients.
Results
Validation of pulsatile and constant corticosterone infusion in
adrenalectomised rats
To model a physiologically realistic ultradian CORT replacement pattern in adrenalectomised
rats, we based our PULS on the endogenous CORT profile during the peak secretory phase, as
determined by frequent blood sampling of adrenally intact male rats at 10 min intervals over a
28 hr period (Fig 1A). As CORT pulses are not synchronised between rats (Figs 1B and S1A–
S1E), the underlying ultradian rhythm is only evident within individual CORT profiles (Fig
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Fig 1. Validation of both the dose and infused patterns of CORT within the circulation of the rat. (A) Blood
samples were taken every 10 min over a 28 hr period. CORT levels gradually increased from basal (Zt 0–6) to maximal
levels at Zt 12:40. Levels decreased from this point returning to baseline by Zt 22. Lights were 12:12 (lights off at Zt 12),
N = 6 and data is expressed as mean ± s.e.m.. (B) Circulating CORT levels from a single rat indicate approx. hourly
oscillations in CORT in a classical ultradian profile which are (C) most discernible during maximal circadian
secretions, as indicated between Zt 11–14. N = 1. (D) 1 ml of CORT (3.84 μM) was delivered intravenously over 3 hrs
in a PULS manner (dashed line) via 20 min (grey bar), hourly CORT infusions at a rate of 1 ml/ hr, whilst the CONS
(solid line) rate of 0.33 ml was maintained throughout the experimental period. Peaks in circulating CORT were
observed at 20 min, 80 min and 120 min (353 ng/ ml ± 42) post each 20 min infusion and was cleared from the
circulation within each 40 min pump cessation at 60 min, 120 min and 180 min (68 ng/ ml ± 20). CONS-induced
sustained circulating levels (222 ng/ ml ± 12) between 10–180 min of infusion. Area under the curve analysis
confirmed no difference in dose delivered per hr. N = 4 and mean ± s.e.m.. (E) Total circulating CORT was measured
from trunk blood samples taken at the point of euthanasia (140 min and 180 min) after either PULS, CONS or VEH.
Two-way ANOVA indicated a significant effect of time, infusion pattern and interaction (p< 0.0001) in response to
infusions. Post-hoc tests indicated significantly raised CORT at PEAK_140 min compared to both NADIR_180 and
VEH (p< 0.0001) time points. In response to CONS, CORT was raised at both 140 min and 180 min compared to
NADIR_180 and VEH (p< 0.0001), but there was a significant reduction in CORT from 140 min at 180 min
(p< 0.01). Lights were 12:12 (Zt 12 lights off as indicated by the top black bar) and represents total blood serum CORT
levels. N = 7 and mean ± s.e.m. and significant comparisons between CORT infused and VEH infused matched time
points indicated by &&&& p<0.0001, between CORT infused time points by �� p<0.01 and ���� p< 0.0001 and
between infusion patterns by $ $ $ $ p< 0.0001.
https://doi.org/10.1371/journal.pgen.1009737.g001
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1B) and most marked during maximal circadian CORT secretion (Fig 1C). To recapitulate
these endogenous ultradian CORT rhythms, 20 min CORT infusions were delivered hourly.
Blood sampling at 10 min intervals showed CORT levels rising for 20 min, before falling rap-
idly as CORT was cleared from the circulation. This pattern was robustly repeated over the 3
hr experimental time course, averaging 374 ± 24 ng/ ml at pulse peak (20 min into each hour)
and 64 ± 6 ng/ ml at pulse nadir (every 60 min) (Fig 1D).
CONS was dose matched to PULS and confirmed by area under the curve analysis. After
the initial transient increase between 0–20 min in circulating CORT (maximal 353 ng/ ml
±42), levels remained relatively stable between 60–180 min (201 ± 51 ng/ ml) (Fig 1D). Liver
samples were taken at exact times corresponding to the third pulse peak (140 min) and nadir
(180 min) of the PULS. CONS and vehicle control infusion (VEH) samples were taken at the
same time points. Circulating CORT levels were confirmed for all rats taken for liver chroma-
tin immunoprecipitation assay (ChIP) processing (Fig 1E).
Genome-wide GR binding is glucocorticoid pattern dependent
Liver samples were assessed for GR binding across the genome using ChIP assay followed by
next generation sequencing (ChIP-Seq). In total, 3,098 sites of significantly increased GR
intensity (relative to VEH) were identified across all groups, indicating sites of binding.
Within these sites, striking CORT pattern-dependent and time-dependent changes were
observed (Fig 2A–2F). Differences in tag density were evident at a subset of sites when com-
paring 140 min pulsatile corticosterone infusion (PEAK_140), 140 min constant corticoste-
rone infusion (CONS_140) and 180 min constant corticosterone infusion (CONS_180), but all
three groups exhibited an overall increase in tag density enrichment relative to both 180 min
pulsatile corticosterone infusion (NADIR_180) and VEH.
Hierarchical clustering (Fig 2G) revealed the global extent of transient GR binding in liver
during PULS. Of the total 3,098 identified binding sites, 2,658 were enriched (relative to VEH)
at the PEAK_140 time point, whereas none were significantly detected at NADIR_180 (Fig
2H), indicating robust and transient GR binding synchronised to the CORT pulse peak. At
CONS_140, approximately half the number (1,273 sites) were enriched (relative to VEH) com-
pared to the matched PULS time point, however, in stark contrast to the complete lack of
enriched sites at NADIR_180 to VEH, 1,953 binding sites were detected at CONS_180 (Fig 2G
and 2H). Despite the increase in number of enriched sites detected at 180 min compared to
140 min of CONS, only 79 of these were found to be significantly differentially enriched in a
direct comparison between time points (Figs 2J and S3C), indicating sustained enrichment
over time at majority of sites during CONS.
As shown in the Venn diagram (Fig 2I), the largest proportion of GR binding sites (33.4%),
were commonly enriched between PEAK_140, CONS_140 and CONS_180 time points.
Almost a third of total sites were uniquely enriched at PEAK_140 (31.0%), whilst just a small
proportion were unique to CONS (12.6%), and an even smaller proportion were exclusively
associated with either CONS_140 (3.0%) or CONS_180 (7.6%).
Interestingly, a very small number of sites were found to have reduced enrichment of GR
(relative to VEH), 50 at PEAK_140 (1.6% of all enriched sites), 10 at CONS_140 (0.3%) and 9
at CONS_180 (0.3%). Tag density distribution plots support these as regions of enrichment
indicative of real binding events (S2F–S2J Fig), although a mechanism explaining how GR
binding can be greater in adrenalectomised rather than in CORT treated rat liver is currently
not well understood.
Together these data show how ultradian GC-dependent GR binding dynamics alter during
constant CORT exposure.
PLOS GENETICS Patterned regulation of glucocorticoid receptors and transcription
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Lack of evidence for a co-factor that determines differential GR binding
dynamics
To identify determinants of liver-specific GR binding, as well as pattern-dependent co-factors,
all significantly enriched sites from the GR ChIP-Seq datasets were analysed for over-repre-
sented de novomotif sequences. Of the top 6, the most confident match (p = e-458) was to the
GRE motif (Fig 2K), followed by CEBPA, HNF4a, STAT5, FOXM1 and AR half-site consensus
sequences. GRE distribution was most distinctly concentrated at the centre of the identified
GR binding regions compared to other motifs (Fig 2L and 2M), further supporting identified
enriched regions as direct GR binding sites as well as indicating specificity at the estimated
location of GR to DNA interaction. Co-occurrence of HNF4α or STAT5 motifs with GREs
was detected in over 50% of GRE-containing regions, while co-occurrence of CEBPA with
GREs was detected in over 35% of GRE-containing regions (S4A Fig). As CEBPA has been
demonstrated to maintain chromatin accessibility for GR binding in liver [29], together with
other transcription factors including HNF4α, our findings most likely reflect these cell type-
specific determinants of GR binding in liver rather than their involvement in determining dif-
ferential responses to patterned GC exposure. The over-representation of STAT5 motifs within
GRE-containing regions also likely reflects the known interactions of these two transcription
factors in regulating a large number of functional groups of genes in liver [30]. Further interro-
gation of sequences underlying pattern-dependent GR binding sites was performed to deter-
mine whether specific motifs were enriched at sites exclusively induced by either PULS or
CONS. Motifs underlying GR binding sites, however, were evenly represented across infusion
pattern and times, indicating that differential GR binding patterns are highly unlikely to be
determined by associated trans-acting factors (S4B and S4C Fig).
RNA polymerase II enrichment in target genes is regulated in a pattern-
dependent manner
To investigate if the observed changes in CORT pattern-dependent GR binding modulates
transcriptional activity, liver chromatin samples were immunoprecipitated using an antibody
specific for a phosphorylated serine 2 residue on the carboxy terminal domain of RNAPol2
(pSer2 Pol2). As the pSer2 Pol2 is associated with the actively transcribing complex [31,32],
intragenic occupancy data serves as a proxy for active transcription at the level of the
chromatin.
pSer2 Pol2 occupancy exhibited dynamic regulation in a CORT time-dependent and pat-
tern-dependent manner that was reflective of the GR binding patterns observed. PEAK_140
Fig 2. Patterned CORT-regulated GR binding at sites across the genome. GR tag intensity and distribution from the centre of 3,980 enrichment
regions in response to (A) PEAK_140, (B) NADIR_180, (C) CONS_140, (D) CONS_180 as well as (E) 140 min and (F) 180 min VEH was visualised
by heatmap. Tag count intensity was normalised to 1 million reads per 1 kb, over a 10 kb region, segmented into 200 bins and is indicated by the
heatmap according to the scale bar. (G) Heatmap indicates GR enrichment fold change within identified regions in the liver in response to either
PULS or CONS at 140 min and 180 min compared to VEH. Heatmap indicates merged replicate tags (N = 2), data was hierarchically clustered
according to fold change (log2) and colour intensity indicates degree of fold change as indicated by the scale bar between -8 to 8 (top right). Total
number of genes differentially regulated is indicated bottom left, number of genes in response to infused CORT time point under each lane as well as
the percentage of total genes. (H) Table describing the number of significant CORT-regulated enrichments compared to VEH. (I) Venn diagram
representing the number of GR binding sites induced by single or multiple CORT infused time points compared to VEH. (J) Graph represents the
number of sites induced compared to NADIR_180 by a single or combination of PEAK_140 and CONS time points. Y-axis of the vertical bar graph
indicates number of sites whilst the dot directly below a bar represent if a site was enriched by a single (black), two (blue) or three (green) CORT
infused time points. Horizontal bar graph indicates the number of sites enriched by each CORT infused time point. (K) Table of the top 6
significantly over-represented sequences within CORT-regulated GR sites to VEH control. Score indicates degree of similarity between de novo and
known motif sequences and motif base logo indicates specific probability (s.p.) of base occurrence. (L-M) Of the most significant motifs, histograms
report the intensity and distribution of the (L) GRE (black), CEBPA (Blue), HNF4α (red), (M) STAT5 (purple), FOXM1 (green) and AR half-site
(grey) motifs 1 kb in either direction from the centre of identified GR enriched regions.
https://doi.org/10.1371/journal.pgen.1009737.g002
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induced transcriptional changes in the largest proportion of total regulated genes (553 genes)
whilst intragenic pSer2 Pol2 occupancy mostly returned to basal levels at NADIR_180 (for 449
genes) with the exception of 104 genes (Fig 3A, 3D and 3E). Interestingly, for both PEAK_140
and NADIR_180, there was decreased pSer2 Pol2 occupancy compared to VEH in approx. 3
out of 4 cases (Fig 3A and 3D) indicating an overall inhibitory transcriptional effect by PULS,
although this was far more pronounced at PEAK_140 due to the transient nature of the vast
majority of the changes. During CONS, differential pSer2 Pol2 enrichment relative to VEH
was detected at both CONS_140 (254 genes) and CONS_180 (278 genes) (Fig 3A). More genes
were up- rather than down-regulated at 140 min (196 and 58 genes respectively), whilst there
was a more similar distribution at 180 min (138 and 140 genes respectively) (Fig 3D).
Consistent with observed GR binding dynamics, the most robust effect on transcriptional
regulation was detected at PEAK_140, in a highly transient profile with a return to basal levels
by NADIR_180 in most cases. In contrast, more moderate changes were detected with CONS,
with lower fold change and fewer genes affected and sustained across both time points (Figs
3A, S3D, S3E and S3F).
Comparative mRNA expression analysis
To assess the impact of the observed highly dynamic patterns of pSer2 Pol2 occupancy to the
liver transcriptome, we performed RNA-Seq expression analysis on liver samples collected at
180 min PULS and CONS. The analysis revealed differential mRNA expression (relative to
VEH) for 282 of the genes identified as differentially occupied by pSer2 Pol2 (39.6% of ChIP tar-
gets) (Figs 3B, 3D and S5). Whilst the direction of change in pSer2 Pol2 occupancy and RNA
expression was found to be largely similar across data sets (Figs 3B, 3D and S5), there was an
interesting exception; the pronounced transient decrease in pSer2 Pol2 occupancy observed at
PEAK_140 did not result in significantly reduced mRNA expression levels at 180 min, for the
majority of cases. Transient reduction was observed in 406 of 453 pSer2 Pol2 differentially occu-
pied genes at PEAK_140 and at 180 min, whilst just 41 of the 144 genes expressions were
reduced in the RNA. Interestingly, the transient increased pSer2 Pol2 occupancy of 147 genes at
PEAK_140 was followed by increased mRNA expression for 103 genes at 180 min (Figs 3C and
S5). Whilst in stark contrast, CONS decreases in pSer2 Pol2 occupancy between 140–180 min
were faithfully accompanied by a significant down-regulation of mRNA at 180mins (146
genes), as was an approx. equal number of up-regulated genes (121 genes) compared to VEH
(Figs 3C and S5). Globally, 1,105 mRNA transcripts were differentially expressed by CORT
infusion, CONS differentially regulated 990 compared to 419 by PULS, representing 89.6% and
37.9% of all transcripts respectively (S6A Fig). Additionally, 679 of these transcripts were differ-
entially expressed by CONS only and no other infused condition, whilst PULS induced 109
(S6B Fig). The similarity between CONS regulation of total RNA-Seq data and the pSer2 Pol2
cohort is intriguing, as globally PULS was overly activatory (277 up- as opposed to 142 down-
regulated) whilst CONS was equally activatory and inhibitory (497 up- to 493 down-regulated)
of mRNA at 180 min despite the greater number of differentially expressed mRNA. Together,
these data indicate transient increases, as opposed to decreases, in pSer2 Pol2 occupancy at
PEAK_140 are more reflective of increased levels of mRNA at 180 min for PULS whilst CONS
is a stronger transcriptional modulator for both up- and down-regulation.
The pSer2 Pol2 ChIP-seq data analysis may provide some insight, as despite PEAK_140
inducing the greater change in pSer2 Pol2 regulation, the changes are short-lived and highly
transient, while the lower but sustained pSer2 Pol2 regulation by CONS has greater effects on
mRNA expression levels, highlighting the complexity of regulation in this highly dynamic
system.
PLOS GENETICS Patterned regulation of glucocorticoid receptors and transcription
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RNAPol2 dynamics reveal evidence for a promoter-proximal pausing
model as well as a relationship between increased or decreased occupancy
predicated by the proximity of an enriched GR binding site
Tag density distribution from the TSS of sense strand coded regions > 10 kb, revealed distinct
increased density between +35 b to +95 b from the TSS across all datasets irrespective of treat-
ment or time point (Fig 3F). As the pSer2 Pol2 complex is associated with the actively tran-
scribing complex throughout the coding region [31,32], this pattern of enrichment may
represent stalled complexes, as proposed within the bimodal, promoter-pausing model of tran-
scription [33,34].
Additionally, an interesting relationship was observed in our data, irrespective of the CORT
infused condition (Fig 3G). When distance of the most proximal GR binding site to a CORT-
regulated TSS was plotted against either increased or decreased pSer2 Pol2 occupied genes, the
25th percentile was closer (9.81 b (log2)) for increasingly compared to decreasingly occupied
targets (14.29 b (log2)) in response to PEAK_140 (Fig 3G(i)). Similar relationships were
observed throughout the percentiles as well as in response to either CONS time point (Fig 3G).
It should be noted there were reduced differences in response to CONS_140 due to the overall
increased transcriptional recruitment compared to other infused conditions (Fig 3G(ii)). This
is consistent with similar mRNA data in A549 cells, however, mechanisms underpinning the
observation are not yet understood [35].
Functional pathway analysis reveals evidence for differential regulation of
key metabolic pathways
Pathway analysis was performed using pSer2 Pol2 significant fold changes as a proxy for tran-
scriptional change and according to published data, significant predictions of activation (z-
score� 2) or inhibition (z-score� -2) were calculated. Trends (z-score 1–2) of transient acti-
vation during pulsatile infusion (synchronised to PEAK_140) but sustained during constant
infusion (across both CONS_140 and CONS_180 time points) were evident for pathways regu-
lating inflammation of liver, concentration of glucose, quantity of glycogen and carbohydrate
(Fig 4A). Interestingly, there was a juxtaposition between necrosis and cell death of hepatoma
cell lines, with proliferation of liver cells which was further compounded by the CONS only
activation of liver growth (Fig 4B). Taken together, these data indicate that glucose and carbo-
hydrate metabolism, as well as hepatocyte cell turn over were more strongly associated with
CONS exposure compared to the same dose of PULS. This is most strongly observed within
Fig 3. Analysis of pSer2 Pol2 intragenic occupancy in response to PULS or CONS after 140 min and 180 min. Heatmap visualises fold change in intragenic pSer2
Pol2 enrichment at CORT infusion-regulated genes in the liver in response to (A) PULS or CONS at 140 min and 180 min compared to VEH. (B) Fold changes of
mRNA transcripts for genes identified by the pSer2 Pol2 analysis in response to pulsatile and constant VEH (left column), pulsatile VEH and CORT (middle) and
constant VEH and CORT after 180 min of infusion. Heatmap indicates merged replicate tags (N = 2), data was hierarchically clustered according to fold change (log2)
and colour intensity indicates degree of fold change as indicated by the scale bar between -8 to 8 (top left) for pSer2 Pol2 and between -5 to 5 (right of middle) for RNA.
Total number of genes differentially regulated is indicated bottom left, number of genes in response to infused CORT time point under each lane as well as the
percentage of total genes. (C) Bar graphs represent no. of genes with a significant fold change from the pSer2 Pol2 data (ChIP) and associated mRNA (RNA). Results
were split into (i) pulsatile CORT infusion and (ii) constant CORT infusions at both 140 min and 180 min. Bars represent all results from a time point, and then split
further into up-regulated and down-regulated results according to pSer2 Pol2 changes. Key indicates significant fold change for pSer2 Pol2 but not mRNA (red),
increased or decreased for both pSer2 Pol2 and mRNA (green), opposing for pSer2 Pol2 and mRNA (yellow), mRNA only (blue) and no significant change for either
pSer2 Pol2 or mRNA (black), as indicated by the key (top). (D) Table describing the number of significantly increased or decreased pSer2 Pol2 occupied and transcribed
genes compared to VEH. (E) Graph represents the number of genes that were regulated in comparison to VEH by a single or combination of PULS and CONS time
points. Y-axis of the vertical bar graph indicates the number of genes whilst the dots represent if a gene was enriched by a single (black), two (blue), three (green) or all
(red) CORT infused time points. Horizontal bar graph indicates the number of genes enriched by each CORT infused time point. (F) Histogram of tag density
distribution -5 kb and +15 kb from the TSS of pSer2 Pol2 differentially regulated genes on the sense strand within coding regions> 10 kb in response to a CORT infused
time point. (G) Genes were split by either gain (solid) or loss (dotted) in pSer2 Pol2 occupancy and percentage of total were plotted against the distance to the most
proximal GR binding site induced by (i) PEAK_140 (black), (ii) CONS_140 (blue) or (iii) CONS_180 (red) time point.
https://doi.org/10.1371/journal.pgen.1009737.g003
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the super-pathway of methionine degradation (Fig 4A), as it was significantly predicted to be
activated at PEAK_140 (z-score 2.24), CONS_140 (z-score 2.45) and CONS_180 (z-score
2.45). This prolonged prediction of activation could induce greater degradation of methionine,
compared to the transient activation in response to PULS.
Other trends of activation / inhibition were predicted for pathways regulating levels of sero-
tonin, melatonin, monosaccharides, triacylglycerols, lipids and fatty acids (Fig 4C). In particu-
lar, significantly predicted inhibition of cholesterol biosynthesis was reported at the
NADIR_180 (z-score -2) with an accompanied strong trend at PEAK-140 (z-score -1.89),
whereas no prediction was made for CONS_140 and a reduced trend at CONS_180 (Z-score
-1), indicating the potential for reduced cholesterol levels in response to PULS. Pathways of
dyslipidemia and hyperlipidemia were also enriched for CORT-regulated genes, corroborating
the known relationship between GCs and these conditions.
Addition to these powerful and novel insights into dynamic CORT regulated genomic tran-
scriptional activity, we further investigated whether changes to the mRNA transcriptome were
also detectable in related metabolic pathways. Gene ontology analysis of the 1,126 differentially
expressed mRNA identified 59 pathways enriched by PULS regulated targets, whilst CONS
regulated targets were enriched in a greatly increased total of 179 pathways (Fig 4D). CONS
was observed to have a greater transcriptional effect as 38 out of the 59 pathways enriched for
PULS regulated targets were also identified in response to CONS with a greater number of
CONS regulated genes associated for each pathway (Fig 4E).
There was a good deal of cross-over between pSer2 Pol2 ChIP and RNA pathway analysis,
despite the acute timeframe. Within RNA gene ontology results, pathways of gluconeogenesis,
fat cell differentiation and sequestering of triglycerides were enriched for PULS regulated
genes whilst triglyceride biosynthesis, liver development and metabolism of glucose, choles-
terol, lipid and fatty acids were for CONS (Fig 4F). Genes within insulin, glucagon, triglyceride
metabolism and circadian rhythm pathways were enriched for both CORT pattern regulated
genes, with CONS regulating a greater number within each pathway.
Together, these analyses demonstrate how functional pathways implicated in metabolic
pathology could be significantly affected by patterned CORT exposure within a relatively acute
3 hr period.
Pathway analysis reveals key CORT pattern regulated genes
Based upon pathway analysis, several key genes were identified with robust CORT pattern-
dependent pSer2 Pol2 changes in occupancy, as well as proximal GR binding within 50 Kb of
their TSS. For example, pSer2 Pol2 occupancy of the key gluconeogenic target serine dehydro-
genase (Sds) was transiently increased by PULS but sustained by CONS, as was GR enrichment
at a site ~-5 kb from the TSS (Fig 4H) which was represented by an increased induction of
mRNA expression by CONS compared to PULS (4.2- and 2.8-fold respectively). Opposingly,
pSer2 Pol2 occupancy of glucose-6-phosphatase catalytic subunit (G6pc) was transiently
decreased (S7B Fig), whilst no change to VEH was detected at solute carrier family 37 member
4 (Slc37a4) (S7A Fig). In response to CONS, no change was found for G6pc, but Slc37a4 was
decreased at both CONS_140 and CONS_180 to VEH. Similar CORT pattern-regulated bind-
ing to Sds was detected -6 kb and -12 kb from the G6pc and at the TSS for Slc37a4. These tar-
gets are important factors within gluconeogenesis and present key evidence glucose
production and efflux could be altered by patterned CORT exposure.
CONS was indicated to have similar effects at key lipogenic targets, potentially increasing
lipogenesis as well as triglyceride formation. For example, LPIN1 oxidises fatty acids for tri-
glyceride formation and induces adipocyte differentiation [36]. Changes in pSer2 Pol2
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indicated the transient increased transcription at PEAK_140, was sustained across time points
by CONS (Fig 4G), and this is consequently associated with a greater fold-change in mRNA to
VEH by CONS (3.5- and 4.4-fold increases respectively). Additionally, transient repression of
apolipoprotein B (ApoB) which is integral to correct very low-density lipoprotein (VLDL)
assembly, was sustained by CONS (S7C Fig). Together, CONS regulation of these targets could
have distinct implication for metabolite deposition within the liver.
Transient increases / decreases in pSer2 Pol2 in response to PULS which are prolonged by
CONS were also observed in key cell death and proliferative factors, such as Myc, Igfbp1 and
Igf1 (S8A, S8B and S8C Fig). Most notably, dynamic increased transcription of Igfbp1 resulted
in significant increased mRNA production in response to CONS only (3.1-fold); further evi-
dence of prolonged changes in active transcription impacting overall levels of mRNA.
Together these key targets indicate transient regulation of glucose and lipogenic processes,
which exhibit the potential to be dysregulated during aberrant CORT exposure. Importantly,
our results have also identified hepatocyte factors regulating turnover rates within the liver to
be highly sensitive to the pattern of GC exposure.
Discussion
For the first time we have been able to demonstrate, in vivo, that hourly PULS not only mimics
physiological endogenous ultradian CORT fluctuations within the circulation of the rat but
also robustly induces GR binding at over 2,500 binding sites synchronised to the peak of a
CORT pulse (PEAK_140), whilst no significantly detectable binding events were found at
NADIR_180. We also present evidence that resultant transcriptional activity is similarly
dynamic, as the occupancy of over 500 genes by pSer2 Pol2 were similarly regulated and syn-
chronised to the CORT pulse peak. These data demonstrate that GC-responsive mechanisms
are sensitive to ultradian oscillations in vivo and reveal new evidence for differential transcrip-
tional outcomes during pulsatile versus constant CORT replacement. For liver transcriptome
regulation, pulsatile CORT induced GR binding and pSer2 Pol2 occupancy of GC-responsive
genes was highly transient, whist in contrast constant CORT exposure induced prolonged GR
binding and dysregulated RNAPol2 dynamic occupancy. This effect led to greater change in
key mRNA targets in response to constant CORT, with potentially adverse impacts on key
functional metabolic pathways in the liver. It was also striking that despite the greater changes
Fig 4. Pathway analysis of differentially regulated genes reveal dynamically CORT-regulated metabolic pathways and targets. (A-C)
Heatmap list pathways identified as enriched for pSer2 Pol2 differentially occupied genes (total no. of genes indicated in brackets) in response
to patterned CORT infusion at 140 min and 180 min compared to VEH. Pathways were sorted into (A) transiently enriched by PULS and
sustained by CONS, (B) enriched by CONS only and (C) enriched at each time point for both infusion patterns VEH. Pathways enriched for
significant changes in pSer2 Pol2 occupied genes, is indicated by p-value � < 0.05, �� < 0.01, ��� < 0.001 and ���� < 0.0001. Predicted
activation of a pathway is indicated by a significant positive (� 2) z-score, whilst inhibition indicated by a negative (� -2) z-score as visualised
by the colour intensity according to scale bar between -2 to 2. (D) Scaled Venn diagram representing the number of pathways identified with
an over-representation of genes regulated by either pulsatile (orange), constant (blue) or both patterns of CORT compared to VEH from the
RNA-Seq data set. (E) Within pathways enriched for pulsatile and constant CORT-pattern-regulated genes, number of genes within each
pathway were plotted for either patterned CORT infusion. (F) Key metabolic pathways enriched for CORT regulated genes was selected and
number of genes plotted in response to either pulsatile (left green) or constant (right yellow) infusions. Pathway analysis was applied to global
RNA-Seq data and over-representation analysis calculated from genes with a log2 fold change> 0.585 and adjusted p-value< 0.05. (G,H) Both
GR and pSer2 Pol2 tag density distribution was visualised using the UCSC genome browser within and extending from the TSS and 3’ end of
three GC-regulated targets in response to PULS (blue), CONS (red) and VEH (black) after 140 min and 180 min. (G) Three GR enriched sites
-2 kb, -5 kb and -8.5 kb from the TSS of Sds were detected; the -5 kb of which was enriched at PEAK_140, CONS_140 and CONS_180 whilst
the other two at PEAK_140 only. pSer2 Pol2 intragenic enrichment was increased in a similarly responsive manner. Data visualised over a
chr12: 41,617,378–41,633,829 region. (H) Two similarly patterned enriched GR binding sites were detected -42 kb and -48 kb of the Lpin1 TSS
as was increased pSer2 Pol2 intragenic enrichment. Data visualised over a chr6: 41,789,357–41,899,861 region. Data visualised over a chr7:
102,581,386–102,596,166 region. All data was merged from two replicates and regions of CORT induced changes in enrichment to VEH are
indicated by black bar below individual tracks. y-axis set to 0–200 and locations of introns and exons (maroon blocks) according to Ensembl
rn6 co-ordinates are indicated as transcribed from the anti-sense strand (right to left–arrow) at the bottom.
https://doi.org/10.1371/journal.pgen.1009737.g004
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to pSer2 Pol2 occupancy at PEAK_140, CONS was a greater regulator of mRNA expression.
Additionally, despite a greater repressive action at PEAK_140 on pSer2 Pol2 occupancy, it was
the increased occupancy that was realised within transcriptomic changes in mRNA whilst
CONS was equally effective for increased and repressed action. We therefore conclude that not
only is the transcriptome sensitive to oscillating levels of endogenous glucocorticoids, but that
the highly transient nature of PULS is not effective at repressing mRNA expression, which
could play a potentially very important role for physiologically appropriate transcriptional reg-
ulation. Our pathway analysis highlighted several metabolic pathways enriched for CORT
responsive targets regulating inflammation, glucose, lipid, carbohydrate, cholesterol regulation
as well as liver growth and death pathways. Whilst these pathways are well known to be regu-
lated by GCs [12,37], this is the first evidence for distinct and opposing transcriptional effects
induced by different patterns of GC exposure. Notably, pulsatile CORT was significantly pre-
dicted to repress cholesterol biosynthesis at 180 min with a trend at 140 min, whilst constant
CORT only predicted a reduced trend of repression at 180 min; a potential risk factor associ-
ated with hypertension, obesity, liver fibrosis and non-alcoholic steatohepatitis (NASH) [38–
40]. Similarly, the impact of constant CORT exposure on prolonged activation of the methio-
nine degradation pathway may be to increase the risk of fatty liver development; a condition
associated with increased methionine metabolites within the liver [41,42]. Furthermore, dysre-
gulation of ultradian CORT responsive genes could have serious adverse consequences for glu-
cose, triglyceride and lipid metabolism, leading to increased risk of developing insulin
resistance, type II diabetes and fatty liver [12,37,43,44], whilst dysregulating growth and apo-
ptotic regulating genes as observed in with NASH and liver fibrotic phenotypes [45–47].
We have also identified CORT-regulated targets and associated GR binding sites which
may have key roles in the development of metabolic syndrome phenotypes in gluconeogenesis,
de novo lipogenesis, substrate production for triglyceride synthesis as well as lipoprotein func-
tion. For example, Sds deaminates serine into the metabolic substrate pyruvate [48], whilst
G6pc and its associated carrier protein Slc37a4 convert glucose-6-phosphate into glucose in a
rate limiting step of gluconeogenesis [49]. Despite changes in mRNA only detected for Sds, if
these changes in genomic transcriptional activity were reflected in the transcriptome over a
prolonged period, the result could be increased glucose production and efflux from hepato-
cytes. Additionally, ApoB is required for VLDL synthesis and function, facilitating lipid accu-
mulation within the lipoprotein as well as endocytosis by intermediate density lipoproteins
and lowering VLDL levels within the circulation [50,51]. As VLDL synthesis and function are
integral to the livers ability to transport triglyceride, lipids and other metabolites, net loss of
ApoB transcription over time in response to CONS could be fundamental, as loss of this pro-
tein could increase deposition and storage within the liver. Known risk factors of non-alco-
holic fatty liver disease and steatosis [52–55]. Therefore, any dysregulation of synthesis over a
prolonged period could have adverse effects.
Furthermore, dysregulating GR dynamics may also impact related endocrine-signalling sys-
tems. For example, growth hormone (GH) is secreted into the circulatory system in an
inversed circadian fashion to CORT, peaking just after the onset of sleep [56,57]. The down-
stream targets of GH include stat5, stat3 and NFκB, which can act as transcriptional-co-factors
with GR in well-established transrepressive mechanisms [58–60]. Therefore, dysregulation of
GR dynamic activity could have serious implications for GH regulated pathways, particularly
when one considers that night-shift workers present with unpredictable GH surges during
their wake periods [57]. Increased bioavailability of active GR—also dysregulated by night-
shift patterns—may then co-operatively increase the risk of metabolic syndrome associated
clinical manifestations.
PLOS GENETICS Patterned regulation of glucocorticoid receptors and transcription
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1009737 August 10, 2021 14 / 28
The importance of trying to reinstate a circadian rhythm in patients on GC replacement
therapy is well recognised [61]. Surprisingly however, despite clinicians’ best attempts to pro-
vide an ‘optimal’ replacement regime, many patients suffer from a range of metabolic and cog-
nitive side effects [19,62]. The prevalence of side effects becomes worse with increasing dose,
especially when using long-acting sGCs. A recent meta-analysis concluded prescription of
dexamethasone and prednisolone were significant risk factors for development of insulin resis-
tance within individuals with no underlying pathology [44] and corticosteroid treatment was
shown to increase the risk of developing type II diabetes in a cohort of patients that did not
present underlying risk factors [18]. Our data provide an ultradian chronobiological mecha-
nism whereby phasic GR recruitment and dissociation from the DNA is needed to optimally
regulate metabolic homeostatic pathways in the liver and a mechanism through which non-
oscillatory activation of glucocorticoid receptors could increase risk of metabolic dysfunction.
Dysregulation of ultradian oscillations, which results in a glucocorticoid profile lacking the
endogenous nadir phase, can increase the transcription of specific genes associated with depo-
sition of triglyceride, cholesterol and carbohydrates within the liver. Coupled with reduced
ApoB expression and correct VLDL synthesis, over a prolonged period the loss of ultradian
oscillations could increase the risk of developing non-alcoholic fatty liver and steatosis
phenotypes.
Previous strategies to reduce the side effect profiles of GCs have not considered the impor-
tance of the pattern of replacement or the difference in binding kinetics for different GC ana-
logues. Since GC hormones are used in such a wide range of diseases and abnormalities of
endogenous GC secretion have been implicated in many stress related and psychiatric condi-
tions, we hope that our findings will contribute to a better appreciation of pulse pattern and
lead to improvements in future therapeutics.
Materials and methods
Ethics statement
All animal procedures were carried out in accordance with the UK Home Office animal wel-
fare regulations and approved by written consent from the Animal Welfare and Ethical Review
Body (University of Bristol).
Surgery and husbandry
Male Sprague-Dawley rats (250–300 g) (Harlan, Bicester, UK) were individually caged in
soundproof rooms under standard conditions with standard chow and water available ad libi-
tum. All CORT infusions were conducted in rats under 14:10 light/dark cycle (lights on at Zt 0
hr) whilst automated blood sampling experiments were under 12:12 light/dark cycle.
Rats were anaesthetised with a combination of Isoflurane (100% w/w liquid vapour (Merial,
UK)) and medical air during bilateral adrenalectomy, jugular vein or/ and carotid artery can-
nulation. The cannula (Smith Medicals, UK) was exteriorised via craniotomy or a vascular
access button and attached to a spring and swivel system (S9 Fig). Post-operative analgesic 1
mg of Carprofen (Rimadyl, Pfizer, UK), 25 μg dexamethasone (Sigma, UK) and 2.5 ml of glu-
cose (5%)/ saline (0.9%) were administered subcutaneously. For 5 days post-surgical recovery,
0.9% saline drinking water was supplemented with 0.15 μg/L of corticosterone (Sigma, UK)
until 16 hours prior to infusion, whereupon 0.9% saline drinking water was provided ad libi-
tum to ensure complete CORT washout from circulation. Implanted cannula was ‘flushed’
daily via withdrawal of blood and replaced with fresh heparinised saline (1:100) to maintain
patency.
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Circulating total blood serum CORT data
Total corticosterone blood serum samples were taken via an in-house automated blood sam-
pler (S9 Fig). 40 μl blood samples were collected every 10 min in 160 μl Heparin: Saline solu-
tion (1:100). Plasma was separated from whole blood by centrifugation at 4000 rpm, 4˚C and
diluted 1 in 50 with citrate buffer, processed in triplicate and incubated overnight in 50 μl of
125I corticosterone tracer (Oxford BioInnovation DSL Ltd, Oxford, UK) with 50 μl of rabbit
anti-rat corticosterone antibody (kindly donated by G. Makara, Hungary). Free/ bound sepa-
ration was performed using charcoal dextran precipitation and centrifuged pellets 125I cortico-
sterone levels recorded using a gamma counter (Wizard-2470, Perkin Elmer, MA).
Concentrations of corticosterone in each plasma sample were interpolated from a standard
curve and intra- and inter-assay coefficient of variation have been established as 16.65% and
13.30%, respectively. Maximal corticosterone levels were identified by area under the curve
analysis.
Infusion profiles
To ensure complete clearance of any extra-adrenal endogenously produced corticosterone, all
experiments were completed between Zt 13–16. In vivo ‘mock’ ultradian pulses were produced
by a programmable pump (PHD Ultra Syringe Pump, Harvard Apparatus, USA) infusing
CORT solution (solubilised 2-hydroxypropyl-β-cyclodextrin (HBC) complex carrier (Sigma,
UK) in (1:100) heparinised, 0.9% saline solution) through the jugular vein at a dose of
3.84 μM. Each pulsatile infusion period began with a 20 min infusion at a rate of 1 ml per hour
followed by cessation for 40 min and repeated hourly for 3 hrs. A sustained CORT-HBC saline
solution was infused at a reduced rate of 0.33 ml per hour. To ensure all infusion lines and can-
nula were free of any air gaps that may have appeared between setup and infusion, the constant
corticosterone infusion initial rate was increased to 1 ml per hour for 10 min before returning
to 0.33 ml per hour. Area under the curve analysis indicated no difference in CORT dose deliv-
ered across the 3 hrs between the PULS (3,9087 ng/ ml X min ± 1,025 S.E.M.) and CONS
(38,969 ng/ ml X min ± 1,007 S.E.M.). HBC dissolved in 0.9% saline solution and delivered in
a pulsatile pattern was used as vehicle control infusion. Euthanasia time points corresponded
to the pulsatile pattern, third corticosterone pulse peak and nadir at 140 min and 180 min
respectively for all infusion patterns. Trunk blood samples were collected for each rat with
40 μl of 0.5 M ethylenediaminetetraacetic acid.
Tissue collection
Liver was dissected and 0.4 g fixed in 1% (v/v) formaldehyde (Sigma, UK), phosphate buffered
saline (1.37 M NaCl, 2.68 mM KCl, 10.14 mM Na2HPO4, pH 7.4) solution for 10 min at room
temperature. Formaldehyde cross-linking was quenched with addition of glycine (final conc.
125 mM) for 5 min and washed three times in ice cold phosphate buffered saline supple-
mented with 2 mM NaF, 0.2 mM sodium orthovanadate and 1X cOmplete protease inhibitor
(Roche Diagnostics). Fixed liver was stored at -80˚C in 0.2 g samples in 500 μl of S1 Buffer (10
mM HEPES, pH 7.9, 10 mM KCl, 15 mM MgCl2, 0.1 mM (EDTA), pH 8) supplemented with
0.5 mM Dithiothreitol and 2 mM NaF, 0.2 mM sodium orthovanadate and 1X cOmplete pro-
tease inhibitor.
Chromatin fragmentation
Samples were thawed slowly on ice and adjusted to a final volume of 1 ml/ sample with supple-
mented S1 buffer and Dounce homogenised. Lysate was centrifuged at 4000 rpm (4˚C) and
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lysed in supplemented (2mM NaF and 0.2 mM sodium orthovanadate and 1X cOmplete pro-
tease inhibitor) sodium dodecyl sulphate (SDS) lysis buffer (2% SDS, 10 mM EDTA, 50 mM
Tris-HCl (pH 8.1)). Chromatin was sonicated using a Branson Sonifier 450 (Branson Ultra-
sonics, Danbury, CT, USA) to 300–500 bp fragments with multiple 10-sec bursts at 10% output
and centrifuged at 13,000 rpm at 4˚C to remove cellular debris from the chromatin suspension.
Sheared chromatin was stored at -80˚C.
ChIP assay
ChIP buffers were prepared in house, as described in the EZ ChIP kit protocol (Upstate Bio-
technology, Lake Placid, NY, USA) with some modifications for use with animal tissue (as
described where relevant). Sheared chromatin was removed from -80˚C storage and thawed
slowly on ice, diluted to 50 μg in 100 μl of SDS lysis buffer and 0.9 ml with supplemented
(2mM NaF, 0.2 mM NaVan and 1X cOmplete protease inhibitor) ChIP dilution buffer (0.01%
SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl pH 8.1, 167 mM NaCl). Inputs
were immunoprecipitated against either a GR antibody cocktail (2 μg of PA1-510A, 4 μl of
PA1511A (Thermo Fisher, USA) and 4 μg of M-20X sc-1004X (Santa Cruz, USA)) or the ser-
ine 2 phosphorylated RNA polymerase II complex (2 μl ab5095 (Abcam, UK)). Rabbit IgG
antibodies were used as negative control (2 μg of sc-2027 (Santa Cruz, USA)). Inputs were
incubated overnight at 4˚C and incubated with protein A Dynabeads for 4 hrs (Sigma-Aldrich,
UK). To reduce non-specific binding, the DNA-Antibody-Dynabead slurries were sequentially
washed with 150 mM salt buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl
pH 8.1), 500 mM salt buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl pH
8.1), LiCl buffer (0.25 M LiCl, 1% IGEPAL-CA630, 1% deoxycholic acid sodium salt, 1 mM
EDTA, 10 mM Tris-HCl pH 8.1) and twice in TE buffer (10 mM Tris-HCl, 1 mM EDTA) (pH
8.0). Complexes were eluted from the Dynabeads in 1% SDS 100 mM and 0.1M NaHCO3.
NaCl was added (300 mM final concentration) and crosslinks reversed overnight at 65˚C.
RNA was removed using RNase treatment (Roche Diagnostics) at 65˚C and protein was
digested using proteinase K (Ambion, Huntington, UK) after adjusting each solution with
EDTA (1 mM final) and Tris-HCl (4 mM final) at 45˚C. DNA was extracted using 25:24:1 phe-
nol-chloroform-isoamyl alcohol (Sigma, UK) followed by 24:1 chloroform-isoamyl alcohol
(Sigma, UK). DNA in the aqueous phase was precipitated overnight at -20˚C in 2.5 VOL 100%
ethanol and 20 μg glycogen (Sigma-Aldrich, UK). DNA was pelleted by centrifugation at
13,000 rpm, 4˚C and washed in 70% Ethanol (13,000 rpm, 4˚C), air dried and suspended in
40 μl nuclease free water (Ambion, Huntington, UK).
ChIP-Seq quality control and alignment
For each ChIP-seq replicate/condition/timepoint, liver samples from 6 rats were collected (72
rats in total). From each replicate/condition/timepoint, 10 x 100ug chromatin aliquots were
prepared and immunoprecipitated with antibodies to either GR or pSer2 Pol2 before pooled,
concentrated using a UniVapo Vacuum concentrator (Transcriptomics facility, UOB) to
approx. 35 μl and sequenced. Note: Two pooled ChIP samples (N = 10 in each) were
sequenced to allow for concordant peak calling analysis as previously described [63]. Library
preparation (TrueSeq SBS v3-HS kit (illumina, US)) and Next-Gen sequencing using the
Illumnina HiSeq2000 platform (Illumina, USA) of the samples was processed at the Advanced
Technology Research Facility (ATRF), National Cancer Institute (NCI-Frederick, MD, USA).
Adapters were removed, filtered for a base quality of 33 and sequence lengths of 50 b were
isolated using Trimmomatic-0.36 [64]. Trimmed FASTQ files were aligned to the rat genome
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(UCSC rn6 assembly) using bowtie2 [65] and duplicate tags removed using SAMtools 1.3.1
[66]. Subsequent analysis was performed using HOMER v4.9 [67].
Counts were normalised to 10 million tags (makeTagDirectory) to allow for cross sample
comparisons and visualised using the UCSC genome browser [68] (http://genome.ucsc.edu/).
Identification of GR ChIP-Seq enriched regions
Enrichment of GR tags to 1% input control, were identified (findPeaks) using relaxed settings
(-F1 -L1 -P.1 -LP.01 -poisson .1 -style factor). Replicate concordance was assessed using an
irreproducible discovery rate (IDR v2.0.3) set to 0.01. Overlapping enrichments between repli-
cates were merged using mergePeaks (HOMER v4.9.1) and filtered according to the IDR esti-
mated confidence threshold. Overlapping confident enrichment regions were merged again
(mergePeaks) to create a single list of enriched GR locations across conditions. Visualisation
of tag densities were done using EASeq v1.101 [69] and gplots (heatmap.2).
Analysis of differential enrichments
Analyses of pSer2 Pol2 ChIP-Seq enrichment was restricted to transcript coding regions larger
than twice the fragment length (> 320b) and limited to 10 Kb from the TSS (Ensemble release
Rnor_6.0.92). Raw input ChIP-Seq tag counts were subtracted from both GR and pSer2 Pol
enrichment regions (annotatePeaks.pl–HOMER v4.9.1).
Differential GR and pSer2 Pol2 enrichment fold changes were assessed to VEH control and
between corticosterone infusion time points using getDiffExpression.pl (HOMER v4.9.1) and
DESeq2 [70]. GR tags were normalised to the count within de novo binding regions whilst
pSer2 Pol2 tags were normalised to total sequenced tags across replicates. Differential GR and
pSer2 Pol2 enrichments were considered significantly different if fold change> 1.5-fold and
FDR< 0.05. All other results were given the value 0. Variants of the same gene were filtered
for the greatest fold change across all conditions and time points. Distances between TSSs and
GR binding regions were assessed using annotatePeaks.pl.
Motif analysis
223 b in either direction from the centre of identified GR enrichment regions (total equal to
twice the average fragment length) were analysed for both de novo and known motifs using
findMotifsGenome.pl (HOMER v4.9.1). Repeat sequences were masked and optimised for
motifs 8, 10 and 12 b long. Calculations of motifs per base pair per peaks were calculated using
de novo motif matrices within HOMER v4.9.1 and histograms indicate location of the motif
relative to the GR binding site centre and plotted using GraphPad Prism v6.07 for Windows
(La Jolla California, USA, www.graphpad.com).
RNA preparation and sequencing
Frozen liver sections were homogenised (Polytron, PT-2100, Kinematica, CH) in TRIzol
(ThermoFisher Scientific, USA). The aqueous phase was separated via chloroform extraction
(Sigma-Aldritch, UK) and centrifugation (10,000 rpm, 4˚C), total RNA extracted, and DNA
digested (miRNAeasy mini, Qiagen, US). Libraries were constructed from 1 μg total RNA
(TrueSeq Stranded Total RNA kit, Illumina, USA) and filtered for a RIN score > 8 and < 10
(Agilent Tape Station, Bioanalyzer, UK) for sequencing (HiSeq 2500, Illumina UK). All sam-
ples were handled according to manufacturer protocols. Adapters removed, sequences
trimmed (bbduk.sh) and FASTQ files aligned to the rat genome (UCSC rn6 assembly).
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RNA-Seq analysis
Exonic co-ordinates according to the Ensemble, Rnor_6.0.92 release were assessed (feature-
Counts) [71], filtered > 10 reads and differential expression of transcripts with a fold
change> 1.5 and FDR< 0.05 assessed via DESeq2 [70]. Visualisation of results were plotted
using gplots (heatmap.2).
pSer2 Pol2 pathway analysis
pSer2 Pol2 ChIP-Seq DESeq2 data were analysed via Ingenuity Pathway Analysis software
(Qiagen Inc., https://www.qiagenbioinformatics.com/products/igenuity-pathway-analysis).
Enrichment of pathways were identified from genes with fold changes� 1.5-fold and adjusted
p-value< 0.05 to VEH based on previously published liver tissue and HepG3, hepatoma, hepa-
tocyte cell lines as well as mice, rat and human data. Positive and negative z-scores represent
either predicted activation (� 2) or inhibition (� -2) respectively of pathways are based upon
the degree of fold change and significance of the individual genes change in expression, the
numbers of genes that act as an upstream regulator to induce and / or inhibit a specific path-
way, adjusted for the number of studies that report this effect, and according to a binomial dis-








p . Where the distribution of
x = ∑ixi = N++N−, the variance of s2x ¼ Ns
2 ¼ N and the adjustment of published findings is
wi ¼




ENSEMBL [72] was used to retrieve genome annotations using biomaRt (v2.44.4) [73,74], org.
Rn.eg.db (v3.11.4), AnnotationDbi (v1.50.3) packages in R. Scaled Venn diagrams were gener-
ated using VennDiagram (v1.6.20) package in R [75]. Gene-ontology [76,77] analysis was per-
formed using ClusterProfiler (v3.16.1) package in R [78,79]. Over-representation analysis was
applied for genes passing adjusted p-value < 0.05 and log2 fold-change > 0.585. All expressed
genes were used as the background in the over-representation analysis and as the input gene
list in the gene-set enrichment analysis [80]. Benjamini-Hochberg correction (adjusted p-
value < 0.05) was used for multiple comparison correction in the pathway analysis. Pathway
analysis results were visualised using custom scripts written in R [81].
Statistical information
Regular two-way ANOVA was used to test for significant pattern, time-dependent and interac-
tions followed by Bonferroni post-hoc testing (p< 0.05). All data is expressed as mean ± s.e.m.
where appropriate.
Supporting information
S1 Fig. 24 hour circulating CORT profiles in individual male Sprague Dawley rats. (A-E)
Blood samples were collected every 10 min over a 24-hour period from rats and total CORT
levels measured in the plasma by radioimmunological assay. Light schedule was 12:12 (on Zt 0
/ off Zt 12) with dark phase indicated by shaded bar along the top of the plot.
(TIF)
S2 Fig. Sequenced GR tag distribution across identified binding regions. (A-E) Tag density
at identified GR enriched regions across conditions was plotted across a series of histograms in
response to (A) VEH, (B) PEAK_140, (C) NADIR_180, (D) CONS_140 and (E) CONS_180.
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(F-J) Histograms of tag density were also plotted at sites with reduced enrichment in response
to CORT infusion compared to VEH. In all cases, for (F) VEH, (G) PEAK_140, (H)
NADIR_180, (I) CONS_140 and (J) CONS_180, robust peaks in tag density were localised at
enrichment centre and reduced to negligible levels within 1 kb in either direction. Raw tags
(log2) of each replicate (N = 2) were segmented in 5 b bins, spanning 5 kb in each direction
from enrichment centre.
(TIF)
S3 Fig. Heatmaps of GR and pSer2 Pol2 enrichment in response to a single or combination
of patterned CORT infusion time points. Results visualised within these heatmaps were
assessed within differentially enriched regions to VEH in response to the indicated pulsatile or
constant CORT infused time point. (A) GR time dependent sites were defined as sites enriched
to VEH in response to pulsatile or constant CORT, that were also significantly regulated
between 140 min and 180 min CORT infused time points. Of those, fold change is visualised
for 140 min relative to 180 min time points for both pulsatile and constant CORT infusion. (B
and C) GR sites identified as differentially enriched relative to VEH were assessed in signifi-
cant fold change comparisons, with (B) PEAK_140 fold changes in enrichment visualised in
comparison to CONS_140 and CONS_180 and (C) NADIR_180 fold changes in enrichment
visualised in comparison to CONS_140 and CONS_180. (D) pSer2 Pol2 time dependent sites
were defined as sites that had been identified as significantly differentially enriched relative to
VEH, then found to have a significantly difference between 140 min and 180 min, with fold
change in 140 min relative to 180 min visualised here for both pulsatile or constant CORT
infusion. (E and F) pSer2 Pol2 sites differentially enriched to VEH by (E) PEAK_140 and (F)
NADIR_180. In both cases, fold changes in enrichment are visualised at these sites compared
to CONS_140 and CONS_180. Heatmap indicates merged replicate tags (N = 2), colour inten-
sity indicates degree of fold change compared to VEH as shown within the -8 to 8 scale bar
and regions of interest clustered by fold changes hierarchically clustered by Euclidean dis-
tances.
(TIF)
S4 Fig. Distribution of motifs within GR enriched regions. (A) Bar graph displays the top 5
most significant motifs discovered within GR bound, GRE containing regions across all CORT
infused time-points. (B) Motifs identified in GR binding regions that were enriched by
PEAK_140 (white), CONS_140 (grey) or CONS_180 (black) time points compared to VEH.
(C) Lanes 1–4 of heatmap indicates fold change in GR enrichment within identified binding
regions in the liver in response to either PLS or CONS at 140 min and 180 min compared to
VEH. Data presents merged replicate tags (N = 2) hierarchically clustered according to fold
change (log2) and colour intensity indicates degree of fold change as indicated by the scale bar
between -8 to 8 (top left). Lanes 5–10 indicate the presence (blue) or not (black) of the motif
indicated at the top of the lane within the GR enriched site (horizontal row of heatmap). De
novomotifs were identified within 233 b regions in either direction from the centre of identi-
fied GR enriched regions.
(TIF)
S5 Fig. Table of differentially occupied pSer2 pol2 genes at 140 min and 180 min and asso-
ciated differentially expressed RNA results at 180 min in response to pulsatile or constant
CORT infusion and compared to VEH. Of the 715 differentially pSer2 Pol2 occupied genes;
results in the top row (row 1) are split into differentially occupied pSer2 Pol2 ChIP only (red),
as well as genes that were differentially occupied and expressed within the RNA-Seq data set
(green) across all CORT infused conditions. Rows 2–5 split data by 140 min and 180 min time
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points in response to pulsatile or constant CORT infusion and whether the increased or
decreased fold change was observed in both data sets (green) or were opposingly increased /
decreased (yellow), the number of non-significant ChIP results (black) and genes whose RNA
was differentially expressed without an associated significant ChIP result (blue). Rows 6–9
split data by up-regulated and down-regulated pSer2 Pol2 occupation at PEAK_140 and
NADIR_140 and RNA expression at 180 min whilst rows 10–13 split data for constant CORT
infusion in the same manner. Data represents fold changes > 1.5 and adjusted p-value < 0.05.
(TIF)
S6 Fig. Differentially expressed RNA in response to 180 min pulsatile, constant or vehicle
infusion. (A) Fold changes of 1,105 differentially expressed exonic RNA transcripts (bottom
left) was visualised for pulsatile vehicle compared to constant vehicle (left), pulsatile CORT
compared to pulsatile vehicle (middle) and constant CORT compared to constant vehicle infu-
sion (right). Heatmap indicates merged replicates (N = 3), colour intensity indicates degree of
fold change compared to VEH as shown within the -6 to 6 scale bar and genes clustered by
log2 fold change values, hierarchically clustered by euclidean distances as indicated by dendro-
gram (far left). Number of genes differentially regulated are indicated under the appropriate
lane. (B) VENN diagram indicates the number of genes differentially expressed by a single or
combination of infused pulsatile / constant CORT or vehicle comparisons, as observed within
the heatmap (A).
(TIF)
S7 Fig. GR and pSer2 Pol2 enrichment in response to patterned CORT infusion at a selec-
tion of key metabolic targets. Both GR and pSer2 Pol2 tag density distribution was visualised
using the UCSC genome browser within and extending from the TSS and 3’ end of three GC-
regulated targets in response to PULS (blue), CONS (red) and VEH (black) after 140 min and
180 min. (A) GR enrichment was identified at the TSS of Slc37a4 in response to PLS_140 and
CONS time points whilst pSer2 Pol2 intragenic enrichment increased in response to CONS
only. Data visualised over a chr8: 48,716,099–48,725,227 region and y-axis set to 200. (B) Simi-
larly, responsive GR enrichment was also detected 6 kb upstream of the G6pc TSS but pSer2
Pol2 intragenic enrichment was lost in response to PEAK_140 only. Data visualised over a
chr10: 89,275,804–89,306,418 region and y-axis set to 200. (C) GR enrichment was identified
in response to PEAK_140 only, 26 kb upstream of the ApoB TSS, whilst intragenic pSer2 Pol2
enrichment was reduced at PEAK_140, CONS_140 and CONS_180 for ApoB. Data visualised
over a chr6: 33,145,813–33,224,922 region and y-axis set to 200. Data was merged from two
replicates, normalised to 10 million tags and visualised using the UCSC genome browser
within and extending from the TSS and 3’ end. Regions of CORT induced changes in enrich-
ment to VEH are indicated by black bar below individual tracks. Scale bar is indicated at the
top and locations of introns and exons (maroon blocks) according to Ensembl rn6 co-ordi-
nates are indicated as transcribed from either the sense (left to right) or anti-sense strand
(right to left) according to arrow direction (bottom).
(TIF)
S8 Fig. GR and pSer2 Pol2 enrichment in response to patterned CORT infusion at a selec-
tion of key metabolic targets. Both GR and pSer2 Pol2 tag density distribution was visualised
using the UCSC genome browser within and extending from the TSS and 3’ end of three GC-
regulated targets in response to PULS (blue), CONS (red) and VEH (black) after 140 min and
180 min. (A) No enriched GR sites were detected 50 kb up- or downstream of theMyc TSS,
but intragenic pSer2 Pol2 enrichment was increased at PEAK_140, CONS_140 and
CONS_180. Data visualised over a chr7: 102,581,386–102,596,166 region and y-axis set to 200.
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(B) CORT responsive GR enrichment was detected 5 kb upstream of the Igfbp1 TSS as was
pSer2 Pol2 intragenic enrichment. Data visualised over a chr14: 87,441,155–87,456,358 and y-
axis set to 200. (C) GR enrichment was detected 37.5 kb downstream within an intronic region
of Igf1 in response to PEAK_140, CONS_140 and CONS_180 as was increased pSer2 Pol2
intragenic enrichment. Data visualised over a chr7: 28,393,595–28,505,212 region and y-axis
for GR set to 200 and pSer2 Pol2 to 100. Data was merged from two replicates, normalised to
10 million tags and regions of CORT induced changes in enrichment to VEH are indicated by
black bar below individual tracks. Scale bar is indicated at the top, y-axis set to 0–200 and loca-
tions of introns and exons (maroon blocks) according to Ensembl rn6 co-ordinates are indi-
cated as transcribed from sense (left to right) or the anti-sense (right to left) strand as
indicated by the arrow (bottom).
(TIF)
S9 Fig. Schematic of programmable pump and automated blood sampling system, related
to Methods, Surgery and Husbandry. Rats implanted with intravenous cannulae were exteri-
orised either via craniotomy or vascular access “button” over the shoulders and attached to
swivel to allow free movement. Solubilised CORT (blue) was infused via programmable pump
(left). Automatic blood sampling system (right) withdrew blood (red) from the intravenous
cannula through the swivel and valve/ switch system powered by a reversible pump. Once the
required volume has been withdrawn, the pump is reversed, and the valves direct the flow to
infuse the same volume of heparinised saline solution (black–top right) back through the intra-
venous cannula. Arrows denote direction of travel.
(TIF)
S1 Data. Raw DESeq2 results from GR ChIP-Seq experiments. Raw output from DESeq2
(HOMER, getDiffExpression.pl) analysis of GR read counts in response to CORT infused
treatments, compared to VEH at de novo enriched regions to 1% input control. Spreadsheet
detail’s chromosomal locations of enrichments (columns A-E) and whether they were
‘Enriched’ for GR tags compared to 1% input control in response to each CORT and VEH
infused time point (F-J), genetic feature information (M-Z), raw tag counts for each replicate
(AA-AJ) and DESeq2 results including log2 fold changes and associated p-values (columns
AK-BW).
(XLSX)
S2 Data. DESeq2 results from GR ChIP-Seq experiments, filtered for significant enrich-
ment by CORT infusion compared to VEH. Raw output from DESeq2 (HOMER, getDiffEx-
pression.pl) of GR read counts in response to CORT infused treatments and compared to
VEH at de novo GR enriched regions to 1% input control. Results have been filtered for log2
fold change > 0.585 or < -0.585 and adjusted p-value < 0.05. Any results that did not meet
these criteria were removed from the data or assigned 0 values in cases where one or more
CORT infused treatments were significantly enriched. Spreadsheet detail’s chromosomal loca-
tions of enrichments (columns A-E) and whether they were ‘Enriched’ for GR tags compared
to 1% input control in response to each CORT and VEH infused time point (F-J), genetic fea-
ture information (M-X), raw tag counts for each replicate (Y-AH) and DESeq2 results includ-
ing log2 fold changes and associated p-values (columns AI-BW).
(XLSX)
S3 Data. GR ChIP-Seq DESeq2 results used to generate heatmaps. First 5 columns indicate
log2 fold change in GR enrichment compared to VEH after PEAK_140, NADIR_180,
CONS_140 and CONS_180 to VEH (columns 2–5). Further six columns indicate if one / mul-
tiple of the top 6 most significant de novo over-represented consensus sequences were found
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within the enrichment region.
(CSV)
S4 Data. DESeq2 results from pSer2 Pol2 ChIP-Seq experiments, filtered for significant
enrichment by CORT infusion compared to VEH. Raw output from DESeq2 (HOMER, get-
DiffExpression.pl) analysis of pSer2 Pol2 read counts in response to CORT infused treatments
and compared to VEH within transcript coding regions restricted to larger than twice the frag-
ment length (> 320b) and limited to 10 Kb from the TSS. Results were filtered for log2 fold
change> 0.585 and adjusted p-value< 0.05 in enrichment. Any results that did not meet
these criteria for any infused time point were removed from the data. Spreadsheet columns
detail’s Ensembl ID (A), gene name (B), enrichment region (C-F), genetic feature information
(G-I), raw tag counts for each replicate(J-S) and log2 fold changes and associated p-values
(T-AW).
(CSV)
S5 Data. Analysis of pSer2 Pol2 occupation DESeq2 results by Ingenuity Pathway Analysis.
Within tab “Raw data”, describes DESeq2 fold change and p-value results used for Ingenuity
Pathway Analysis. Columns describe Ensemble gene ID (A, B) and gene name (C) as well as
log fold change, log2 fold change, p-value and adjusted p-value for PEAK_140 (D-G),
NADIR_180 (H-K), CONS_140 (L-O) and CONS_140 (P-S) comparisons to VEH. Within tab
“IPA results–pathway Z scores”, describes Ingenuity Pathway Analysis z-scores for each path-
way. Columns describe pathway (A) and the z-score in response to PEAK_140 (B),
NADIR_180 (C), CONS_140 (D) and CONS_180 (E) compared to VEH. Within tab “Heat-
map Z scores”, describes the results used to plot Fig 4A, 4B and 4C. Columns describe pathway
(A) and the z-score in response to PEAK_140 (B), NADIR_180 (C), CONS_140 (D) and
CONS_180 (E) in comparison to VEH. Within tab “IPA results–sig. gene”, describes differen-
tially enriched genes known to either ‘activate’ or ‘inhibit’ pathways visualised in Fig 4A–4C.
Columns describe pathway (A), the differentially regulated gene name (B) and the log2 fold
change in response to PEAK_140 (C), NADIR_180 (D), CONS_140 (E) and CONS_180 (F) in
comparison to VEH. Genes are labelled as either known to be activatory (Act) or inhibitory
(Inh) (G) within that pathway.
(XLSX)
S6 Data. Raw DESeq2 results from RNA-Seq experiments in response to CORT infusion
compared to VEH. Raw, normalised count output from DESeq2 (HOMER, getDiffExpres-
sion.pl) of exonic RNA-Seq count data in response to CORT infused treatments compared to
VEH. Spreadsheet detail’s Ensembl ID followed by the baseMEAN (average normalised count
values divided by the size of factors over all samples), log2 fold change values, the standard
error and both p-value and adjusted p-value of the observation for VEH, PULS and CONS.
(CSV)
S7 Data. Filtered DESeq2 results for significant fold change in enrichment of mRNA in
response to pulsatile or constant CORT infusion compared to VEH. Raw, normalised count
output from DESeq2 (R) of exonic RNA-Seq count data in response to CORT infused treat-
ments and compared to VEH. Results were filtered for log2 fold change > 0.585 or< -0.585
and adjusted p-value < 0.05 in enrichment. Any results that did not meet these criteria were
removed from the data or assigned 0 values in cases where 1 or more CORT infused treatments
were significantly occupied. Spreadsheet columns detail’s Ensembl ID and gene name (A, B)
followed by the baseMEAN (average normalised count values divided by the size of factors
over all samples), log2 fold change value and adjusted p-value of the observation for VEH (C,
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D), PULS (E, F) and CONS (G, H).
(CSV)
S8 Data. Pathway analysis of differentially regulated RNA-Seq genes in response to CORT
infusion compared to VEH. Gene Ontology, KEGG, Reactome and WIKI pathway analysis of
unfiltered RNA-Seq DESeq2 data in response to pulsatile or constant CORT infusion com-
pared to pulsatile or constant VEH respectively. Results for pulsatile and constant infusion are
on separate sheets, and each spreadsheet details process ID, brief description of pathway and
rank (BD) as well further detailed information (E-J) for each analysis.
(XLSX)
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